initi evalu human monoclon anti-lipid antibodi patient sepsi syndrom human monoclon immunoglobulin antibodi lipid domain endotoxin septic patient safeti pharmacokinet immunogen antibodi thirty-four patient singl infus mg mg mg day treatment serum level infus infus radiometr assay one-compart pharmacokinet model fit serum level chang level time dose group mean sem appar volum distribut ml/kg mean serum clearanc ml/kg.h mean serum half-lif mean serum level hour dose micrograms/ml mean concentr micrograms/ml dose presenc gram-neg bacteri infect volum distribut serum clearanc advers reaction antibodi patient data pharmacokinet one-compart pharmacokinet model safe nonimmunogen patient sepsi 